|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
|
EVGN
|
Evogene
|
US
|
NASDAQ
|
|
EVO
|
Evotec SE
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FBT
|
First Trust Amex Biotech Index Fund
|
US
|
AMEX
|
|
FDMT
|
4D Molecular Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
US
|
NASDAQ
|
|
FLGT
|
Fulgent Genetics, Inc.
|
US
|
NASDAQ
|
|
FN
|
Fabrinet
|
US
|
NYSE
|
|
FNCH
|
Finch Therapeutics Group, Inc.
|
US
|
NASDAQ
|
|
FREQ
|
Frequency Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FRLN
|
Freeline Therapeutics Holdings plc
|
US
|
NASDAQ
|
|
FRTX
|
Fresh Tracks Therapeutics
|
US
|
NASDAQ
|
|
FSTX
|
F-star Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FWBI
|
First Wave BioPharma, Inc.
|
US
|
NASDAQ
|
|
GANX
|
Gain Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GBIO
|
Generation Bio Co.
|
US
|
NASDAQ
|